Windlas Biotech Limited (WINDLAS) — Financial Flexibility Index
Windlas Biotech Limited (WINDLAS) has a Financial Flexibility Index of 0.04x as of September 2023. Free cash flow of Rs66.60 Million (operating CF Rs66.60 Million minus capex Rs0.00) represents 0% of total liabilities (Rs1.54 Billion). Check WINDLAS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Windlas Biotech Limited Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Windlas Biotech Limited across 8 annual periods. For the full cash flow conversion analysis, see Windlas Biotech Limited operating cash flow efficiency.
Annual Financial Flexibility Index for Windlas Biotech Limited (2018–2025)
Year-by-year free cash flow to debt coverage for Windlas Biotech Limited. Explore Windlas Biotech Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | Rs1.20 Billion | Rs681.87 Million | Rs2.55 Billion | ▼ -43.2% |
| 2024 | 0.83x | Rs1.47 Billion | Rs1.09 Billion | Rs1.76 Billion | ▼ -20.1% |
| 2023 | 1.04x | Rs1.32 Billion | Rs609.65 Million | Rs1.27 Billion | ▲ +318.4% |
| 2022 | 0.25x | Rs239.34 Million | Rs91.30 Million | Rs962.33 Million | ▲ +39.4% |
| 2021 | 0.18x | Rs173.01 Million | Rs114.54 Million | Rs970.04 Million | ▼ -43.0% |
| 2020 | 0.31x | Rs403.16 Million | Rs250.06 Million | Rs1.29 Billion | ▲ +18.6% |
| 2019 | 0.26x | Rs276.08 Million | Rs186.54 Million | Rs1.05 Billion | ▼ -21.4% |
| 2018 | 0.34x | Rs553.73 Million | Rs295.91 Million | Rs1.65 Billion | — |